ASCO: Durvalumab plus FLOT useful for resectable gastric, GE junction most cancers
For sufferers with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil,…
ASCO: Vepdegestrant ups survival in ER+, HER2− superior breast most cancers with ESR1 mutations
For sufferers with estrogen receptor (ER)-positive, human epidermal progress issue receptor 2…
‘Asco: With out Permission’ honors 4 East L.A. buddies who modified Chicano artwork
Within the Nineteen Seventies and ‘80s, traces of the artist collective Asco,…